PE20020295A1 - Composiciones de oxazolidinona, ampicilina y sulbactam - Google Patents
Composiciones de oxazolidinona, ampicilina y sulbactamInfo
- Publication number
- PE20020295A1 PE20020295A1 PE2001000643A PE2001000643A PE20020295A1 PE 20020295 A1 PE20020295 A1 PE 20020295A1 PE 2001000643 A PE2001000643 A PE 2001000643A PE 2001000643 A PE2001000643 A PE 2001000643A PE 20020295 A1 PE20020295 A1 PE 20020295A1
- Authority
- PE
- Peru
- Prior art keywords
- sulbactam
- ampicillin
- phenyl
- oxazolidinone
- alcoxy
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical group O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 2
- KMEGBUCIGMEPME-LQYKFRDPSA-N (2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(1r,4s)-3,3-dimethyl-2,2,6-trioxo-2$l^{6}-thiabicyclo[3.2.0]heptane-4-carboxylic acid Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)C2C(=O)C[C@H]21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 KMEGBUCIGMEPME-LQYKFRDPSA-N 0.000 title 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 150000003973 alkyl amines Chemical class 0.000 abstract 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 abstract 2
- 229960000723 ampicillin Drugs 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 abstract 2
- 229960005256 sulbactam Drugs 0.000 abstract 2
- -1 AMINO Chemical class 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 150000003869 acetamides Chemical class 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000008119 colloidal silica Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229950008631 eperezolid Drugs 0.000 abstract 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 abstract 1
- 229960003907 linezolid Drugs 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- SIMWTRCFFSTNMG-AWEZNQCLSA-N n-[[(5s)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCN(C(=O)CO)CC1 SIMWTRCFFSTNMG-AWEZNQCLSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920000098 polyolefin Polymers 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229940069328 povidone Drugs 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION CON ACTIVIDAD ANTIBACTERIAL DE AMPLIO ESPECTRO QUE COMPRENDE a)OXAZOLIDINONA DE FORMULA I; X ES O, S, SO, SO2, SNR11, NCOR11, SONR11, n ES 0-2; R ES H, ALQUILO C1-C8 OPCIONALMENTE SUSTITUIDO CON F, Cl, ALCOXI C1-C8, ACILOXIC1-C8, CH2-FENIL, CILOALQUILO C3-C6, AMINO, ALQUILAMINO C1-C8, DIALQUILAMINO C1-C8, ALCOXI C1-C6; R1 ES H, EXCEPTO CUANDO X ES O; R1 ES H, CH3, CN, CO2H, (CH2)mR10; m ES 1-2; R2 ES H, F, Cl; R3 ES H, EXCEPTO CUANDO X ES O Y R1 ES CH3; R3 ES H, CH3; R10 ES H, OH, OR, OCOR, NH2, NHCOR, N(R11)2; R11 ES H, p-TOLUENSULFONIL, ALQUILO C1-C4 OPCIONALMENTE SUSTITUIDO CON Cl, F, OH, ALCOXI C1-C8, AMINO, ALQUILAMINO C1-C8, DIALQUILAMINO C1-C8; SON COMPUESTOS PREFERIDOS LINEZOLID (200mg A 900mg), EPEREZOLID, (S)-N-[[3-[3-FLUORO-4-(TETRAHIDRO-2H-TIOPIRAN-4-IL)FENIL]-2-OXO-5-OXAZOLIDINIL]METIL]ACETAMIDAS, S,S DIOXIDO; (S)-N-[[3-[3,5-DIFLUORO-4-(TETRAHIDRO-2H-TIOPIRAN-4-IL)FENIL]-2-OXO-5-OXAZOLIDINIL]METIL]ACETAMIDA S,S DIOXIDO; b)AMPICILINA; c)SULBACTAM; d)EXCIPIENTES COMO MANITOL, ALMIDON, SILICE COLOIDAL, POVIDONA, ESTEARATO DE MAGNESIO. LA COMPOSICION SE CARACTERIZA PORQUE EL AGENTE ACTIVO ESTA RODEADO DE UN RECEPTACULO QUE COMPRENDE AL MENOS 50% DEL PESO EN POLIOLEFIN Y LA CANTIDAD ANTIBACTERIALMENTE POTENCIADORA DE SULBACTAM Y AMPICILINA ES DE 3.1mg A 6.2mg.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21541800P | 2000-06-30 | 2000-06-30 | |
| US23277300P | 2000-09-15 | 2000-09-15 | |
| US27930601P | 2001-03-28 | 2001-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020295A1 true PE20020295A1 (es) | 2002-04-07 |
Family
ID=27396119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000643A PE20020295A1 (es) | 2000-06-30 | 2001-06-28 | Composiciones de oxazolidinona, ampicilina y sulbactam |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6544991B2 (es) |
| EP (1) | EP1301207B1 (es) |
| JP (1) | JP2004501965A (es) |
| AR (1) | AR029544A1 (es) |
| AT (1) | ATE301474T1 (es) |
| AU (1) | AU2001272961A1 (es) |
| DE (1) | DE60112581T2 (es) |
| DK (1) | DK1301207T3 (es) |
| ES (1) | ES2245698T3 (es) |
| MY (1) | MY128739A (es) |
| PE (1) | PE20020295A1 (es) |
| PT (1) | PT1301207E (es) |
| TW (1) | TWI265030B (es) |
| WO (1) | WO2002002095A2 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| WO2003030906A1 (en) * | 2001-10-11 | 2003-04-17 | Pharmacia & Upjohn Company | Treating infections by administration of oxazolidinones to the skin |
| CN1642543A (zh) * | 2002-03-29 | 2005-07-20 | 法玛西雅厄普约翰有限责任公司 | 治疗糖尿病性足部感染的噁唑烷酮肠胃外、静脉内和口服给药 |
| WO2003093247A2 (en) * | 2002-04-30 | 2003-11-13 | Orchid Chemicals & Pharmaceuticals Ltd | Antibacterial agents |
| JP2008540431A (ja) * | 2005-05-06 | 2008-11-20 | ワイス | ヘパリンの存在下でのチゲサイクリンの送達 |
| JP2008544979A (ja) | 2005-06-29 | 2008-12-11 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗菌剤としてのホモモルホリンオキサゾリジノン |
| WO2007086013A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising of ceftazidime, tazobactam and linezolid |
| WO2007086014A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefpirome, tazobactam and linezolid |
| WO2007086011A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefepime, tazobactam and linezolid |
| WO2007086012A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation of cefpodoxime, clavulanic acid and linezolid |
| WO2008090570A1 (en) * | 2007-01-25 | 2008-07-31 | Panacea Biotec Ltd | Novel antimicrobials |
| KR20110092309A (ko) | 2008-11-20 | 2011-08-17 | 파나세아 바이오테크 리미티드 | 신규 항균제 |
| MX2012000231A (es) | 2009-06-26 | 2012-03-07 | Panacea Biotec Ltd | Nuevos aza-biciclo-hexanos. |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| WO2021184339A1 (en) | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985648A (en) | 1958-10-06 | 1961-05-23 | Doyle Frank Peter | Alpha-aminobenzylpenicillins |
| GB902703A (en) | 1960-08-25 | 1962-08-09 | Beecham Res Lab | Penicillins |
| BE641785A (es) | 1962-12-26 | |||
| US4234579A (en) | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
| SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| ES2165516T3 (es) | 1995-09-01 | 2002-03-16 | Upjohn Co | Feniloxazolidinonas con un enlace c-c con anillos heterociclicos de 4-8 miembros. |
| DE19601264A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
| DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
| DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
| US5684024A (en) | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| ES2166073T3 (es) | 1996-04-11 | 2002-04-01 | Upjohn Co | Procedimiento para preparar oxazolidinonas. |
| SK286569B6 (sk) | 1997-11-07 | 2009-01-07 | Pharmacia & Upjohn Company | Spôsob výroby oxazolidinónov |
| KR20010101890A (ko) | 1999-02-01 | 2001-11-15 | 로렌스 티. 마이젠헬더 | 황-함유 시클릭 플루오르화 옥사졸리디논의 제조 방법 |
-
2001
- 2001-06-21 EP EP01952176A patent/EP1301207B1/en not_active Expired - Lifetime
- 2001-06-21 WO PCT/US2001/019712 patent/WO2002002095A2/en not_active Ceased
- 2001-06-21 DK DK01952176T patent/DK1301207T3/da active
- 2001-06-21 ES ES01952176T patent/ES2245698T3/es not_active Expired - Lifetime
- 2001-06-21 US US09/886,641 patent/US6544991B2/en not_active Expired - Fee Related
- 2001-06-21 JP JP2002506717A patent/JP2004501965A/ja active Pending
- 2001-06-21 PT PT01952176T patent/PT1301207E/pt unknown
- 2001-06-21 DE DE60112581T patent/DE60112581T2/de not_active Expired - Fee Related
- 2001-06-21 AT AT01952176T patent/ATE301474T1/de not_active IP Right Cessation
- 2001-06-21 AU AU2001272961A patent/AU2001272961A1/en not_active Abandoned
- 2001-06-28 PE PE2001000643A patent/PE20020295A1/es not_active Application Discontinuation
- 2001-06-29 AR ARP010103125A patent/AR029544A1/es unknown
- 2001-06-29 MY MYPI20013131A patent/MY128739A/en unknown
- 2001-06-29 TW TW090115958A patent/TWI265030B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK1301207T3 (da) | 2005-10-10 |
| EP1301207B1 (en) | 2005-08-10 |
| ES2245698T3 (es) | 2006-01-16 |
| PT1301207E (pt) | 2005-11-30 |
| US20020022610A1 (en) | 2002-02-21 |
| TWI265030B (en) | 2006-11-01 |
| DE60112581D1 (de) | 2005-09-15 |
| DE60112581T2 (de) | 2006-06-01 |
| US6544991B2 (en) | 2003-04-08 |
| ATE301474T1 (de) | 2005-08-15 |
| MY128739A (en) | 2007-02-28 |
| AR029544A1 (es) | 2003-07-02 |
| JP2004501965A (ja) | 2004-01-22 |
| AU2001272961A1 (en) | 2002-01-14 |
| WO2002002095A3 (en) | 2003-02-06 |
| WO2002002095A2 (en) | 2002-01-10 |
| WO2002002095B1 (en) | 2004-03-25 |
| EP1301207A2 (en) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020295A1 (es) | Composiciones de oxazolidinona, ampicilina y sulbactam | |
| PE20020544A1 (es) | Derivados de indolilmaleimida | |
| KR950701327A (ko) | 치환된 디아진 잔기를 함유하는 옥사졸리디논 항균제(oxazolidinone antimicrobials containing substituted diazine moieties) | |
| PE20010931A1 (es) | Oxazolidinonas que tienen la funcion de una sulfoximina | |
| PE20010851A1 (es) | Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina | |
| KR960704866A (ko) | 치환된 옥사진 및 티아진 옥사졸리디논 항균물질 (substituted oxazine and thiazine oxazolidinone antimicrobials) | |
| PE20020578A1 (es) | Una composicion de antibiotico topico para el tratamiento de infecciones oculares | |
| AR027261A1 (es) | Linezolid forma cristalina ii | |
| PE20011089A1 (es) | Tioamidas de oxazolidinona con sustituyentes de piperazin-amida | |
| PE20080972A1 (es) | Inhibidores de rho cinasa | |
| GB0402653D0 (en) | Compounds | |
| PT1283839E (pt) | Antagonistas do receptor a2a da adenosina | |
| CA2568356A1 (en) | Bicyclic heterocycles as hiv integrase inhibitors | |
| MXPA02006317A (es) | Nuevos moduladores de neurotransmision de dopamina. | |
| PE20081493A1 (es) | Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso | |
| NO980855D0 (no) | Fenyloksazolidinoner med en C-C-binding til 4-8-leddede heterosykliske ringer | |
| MY138386A (en) | Process for the preparation of a solid, orally administrable pharmaceutical composition | |
| AR036906A1 (es) | Compuestos de imidazopiridin como moduladores del receptor 5-ht4 | |
| PE20040728A1 (es) | Inhibidores de caspasa | |
| PE20050420A1 (es) | Fenacilo 2-hidroxi-3-diaminoalcanos | |
| JP2009526832A5 (es) | ||
| DE69818294D1 (de) | Oxazolidinone derivate und pharmazeutische zusammensetzungen | |
| HUP0102099A2 (hu) | Szubsztituált 2-oxo-alkánsav-[2-(indol-3-il)-etil]-amid-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| PE20010166A1 (es) | Nuevas oxazolidinonas biciclicas como agentes antibacterianos | |
| PE20080311A1 (es) | Derivados de oxadiazol como agentes afines a receptores nicotinicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |